COGLAVAX
COGLAVAX
Authorised
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type D, epsilon toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium tetani, toxoid
- Clostridium septicum, toxoid
- Clostridium novyi, type B, toxoid
- Clostridium chauvoei, strain Hung 89, Inactivated
Product identification
Medicine name:
COGLAVAX
Active substance:
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type D, epsilon toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium tetani, toxoid
- Clostridium septicum, toxoid
- Clostridium novyi, type B, toxoid
- Clostridium chauvoei, strain Hung 89, Inactivated
Target species:
-
Cattle
-
Rabbit (for reproduction)
-
Rabbit
-
Sheep
-
Goat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium perfringens, type A, alpha toxoid4.00international unit(s)1.00unit(s)
-
Clostridium perfringens, type D, epsilon toxoid10.00international unit(s)1.00unit(s)
-
Clostridium perfringens, type C, beta toxoid20.00international unit(s)1.00unit(s)
-
Clostridium tetani, toxoid5.00international unit(s)1.00unit(s)
-
Clostridium septicum, toxoid5.00international unit(s)1.00unit(s)
-
Clostridium novyi, type B, toxoid7.00international unit(s)1.00unit(s)
-
Clostridium chauvoei, strain Hung 89, Inactivated1.00100% protective dose1.00unit(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
All relevant tissues0day
-
- Rabbit (for reproduction)
-
All relevant tissues0day
-
- Rabbit
-
All relevant tissues0day
-
- Sheep
-
All relevant tissues0day
-
- Goat
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB01
- QI03AB
- QI04AB01
- QI08AB
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Cz Veterinaria S.A.
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/5726681 3/1982
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 27/09/2023
How useful was this page?: